Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Am J Psychiatry

Retrieve available abstracts of 109 articles:
HTML format

Single Articles

    May 2022
  1. GE R, Humaira A, Gregory E, Alamian G, et al
    Predictive Value of Acute Neuroplastic Response to rTMS in Treatment Outcome in Depression: A Concurrent TMS-fMRI Trial.
    Am J Psychiatry. 2022 May 18:appiajp21050541. doi: 10.1176/appi.ajp.21050541.
    PubMed     Abstract available

  2. PAN PM, Sato JR, Paillere Martinot ML, Martinot JL, et al
    Longitudinal Trajectory of the Link Between Ventral Striatum and Depression in Adolescence.
    Am J Psychiatry. 2022 May 18:appiajp20081180. doi: 10.1176/appi.ajp.20081180.
    PubMed     Abstract available

    April 2022
  3. KEEFE RSE, Canadas E, Farlow D, Etkin A, et al
    Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults.
    Am J Psychiatry. 2022 Apr 12:appiajp21020125. doi: 10.1176/appi.ajp.21020125.
    PubMed     Abstract available

    February 2022
  4. MARKOWITZ JC, Wright JH, Peeters F, Thase ME, et al
    The Neglected Role of Psychotherapy for Treatment-Resistant Depression.
    Am J Psychiatry. 2022;179:90-93.

  5. WEISSMAN CR, Daskalakis ZJ
    Accelerated Intermittent Theta Burst Stimulation: Expediting and Enhancing Treatment Outcomes in Treatment-Resistant Depression.
    Am J Psychiatry. 2022;179:85-87.

    Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression.
    Am J Psychiatry. 2022;179:83-84.

  7. FAVA M, Stahl S, Pani L, De Martin S, et al
    REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.
    Am J Psychiatry. 2022;179:122-131.
    PubMed     Abstract available

  8. COLE EJ, Phillips AL, Bentzley BS, Stimpson KH, et al
    Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial.
    Am J Psychiatry. 2022;179:132-141.
    PubMed     Abstract available

    January 2022
  9. KVARTA M, Ma Y, Hong LE
    Comment on "Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank".
    Am J Psychiatry. 2022;179:73.

    December 2021
    Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg.
    Am J Psychiatry. 2021;178:1130-1132.

    Increased Inflammation in Depression: A Little in All, or a Lot in a Few?
    Am J Psychiatry. 2021;178:1077-1079.

  12. KALIN NH
    New Insights Into Major Depression and the Treatment of Bipolar Depression.
    Am J Psychiatry. 2021;178:1071-1074.

  13. CONROY SK, Holtzheimer PE
    Neuromodulation Strategies for the Treatment of Depression.
    Am J Psychiatry. 2021;178:1082-1088.
    PubMed     Abstract available

    Slowly Working Toward More Treatments for Depression in Bipolar II Disorder.
    Am J Psychiatry. 2021;178:1075-1076.

    Mechanisms of Action of Ketamine and Esketamine.
    Am J Psychiatry. 2021;178:1130.

  16. REUS VI
    Recommendations for the Usage of Ketamine and Esketamine.
    Am J Psychiatry. 2021;178:1129.

  17. ZHUKOVSKY P, Anderson JAE, Coughlan G, Mulsant BH, et al
    Coordinate-Based Network Mapping of Brain Structure in Major Depressive Disorder in Younger and Older Adults: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2021;178:1119-1128.
    PubMed     Abstract available

  18. CALABRESE JR, Durgam S, Satlin A, Vanover KE, et al
    Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
    Am J Psychiatry. 2021;178:1098-1106.
    PubMed     Abstract available

    November 2021
  19. KEDING TJ, Heyn SA, Russell JD, Zhu X, et al
    Differential Patterns of Delayed Emotion Circuit Maturation in Abused Girls With and Without Internalizing Psychopathology.
    Am J Psychiatry. 2021;178:1026-1036.
    PubMed     Abstract available

    October 2021
  20. FRANK P, Jokela M, Batty GD, Cadar D, et al
    Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies.
    Am J Psychiatry. 2021 Oct 14:appiajp202120121776.
    PubMed     Abstract available

  21. KALIN NH
    Depression and Schizophrenia: Sleep, Medical Risk Factors, Biomarkers, and Treatment.
    Am J Psychiatry. 2021;178:881-884.

    The Evolving Nexus of Sleep and Depression.
    Am J Psychiatry. 2021;178:896-902.
    PubMed     Abstract available

    Surrogate Markers of Insulin Resistance in Predicting Major Depressive Disorder: Metabolism Metastasizes to the Brain.
    Am J Psychiatry. 2021;178:885-887.

  24. WATSON KT, Simard JF, Henderson VW, Nutkiewicz L, et al
    Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study.
    Am J Psychiatry. 2021;178:914-920.
    PubMed     Abstract available

    July 2021
  25. ROXAS N, Ahuja C, Isom J, Wilkinson ST, et al
    A Potential Case of Acute Ketamine Withdrawal: Clinical Implications for the Treatment of Refractory Depression.
    Am J Psychiatry. 2021;178:588-591.

    June 2021
    Using the Power of a Giant Wisely: Confirming Inflammation in Depression.
    Am J Psychiatry. 2021;178:480-482.

  27. KALIN NH
    COVID-19 and Stress-Related Disorders.
    Am J Psychiatry. 2021;178:471-474.

  28. RUBINOW DR, Lasser R, Kanes SJ
    Comment on "Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids".
    Am J Psychiatry. 2021;178:572-573.

    May 2021
  29. PITHAROULI MC, Hagenaars SP, Glanville KP, Coleman JRI, et al
    Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank.
    Am J Psychiatry. 2021 May 14:appiajp202020060947.
    PubMed     Abstract available

  30. MAIXNER DF, Weiner R, Reti IM, Hermida AP, et al
    Electroconvulsive Therapy Is an Essential Procedure.
    Am J Psychiatry. 2021;178:381-382.

    Can Target Engagement Studies Miss Their Targets and Mislead Drug Development?
    Am J Psychiatry. 2021;178:372-374.

  32. FERRARELLI F, Phillips ML
    Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments.
    Am J Psychiatry. 2021;178:400-413.
    PubMed     Abstract available

    April 2021
  33. KALIN NH
    Anxiety, Depression, and Suicide in Youth.
    Am J Psychiatry. 2021;178:275-279.

  34. PARIKH T, Walkup JT
    The Future of Ketamine in the Treatment of Teen Depression.
    Am J Psychiatry. 2021;178:288-289.

    The Trifecta of Misery and Disease Vulnerability: Poverty, Childhood Maltreatment, and Inflammation.
    Am J Psychiatry. 2021;178:282-284.

  36. BOELEN PA, Lenferink LIM, Spuij M
    CBT for Prolonged Grief in Children and Adolescents: A Randomized Clinical Trial.
    Am J Psychiatry. 2021;178:294-304.
    PubMed     Abstract available

  37. SEQUEIRA SL, Silk JS, Ladouceur CD, Hanson JL, et al
    Association of Neural Reward Circuitry Function With Response to Psychotherapy in Youths With Anxiety Disorders.
    Am J Psychiatry. 2021;178:343-351.
    PubMed     Abstract available

  38. BIERMAN KL, Heinrichs BS, Welsh JA, Nix RL, et al
    Reducing Adolescent Psychopathology in Socioeconomically Disadvantaged Children With a Preschool Intervention: A Randomized Controlled Trial.
    Am J Psychiatry. 2021;178:305-312.
    PubMed     Abstract available

    March 2021
  39. MCINTYRE RS, Rosenblat JD, Nemeroff CB, Sanacora G, et al
    Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
    Am J Psychiatry. 2021 Mar 17:appiajp202020081251.
    PubMed     Abstract available

  40. DWYER JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, et al
    Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
    Am J Psychiatry. 2021 Mar 3:appiajp202020010018.
    PubMed     Abstract available

  41. COSTI S, Morris LS, Kirkwood KA, Hoch M, et al
    Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
    Am J Psychiatry. 2021 Mar 3:appiajp202020050653.
    PubMed     Abstract available

    One Small Step for PMDD, One Large Step for Affective Disorders.
    Am J Psychiatry. 2021;178:215-217.

  43. COMASCO E, Kopp Kallner H, Bixo M, Hirschberg AL, et al
    Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
    Am J Psychiatry. 2021;178:256-265.
    PubMed     Abstract available

  44. KLEINMAN RA, Schatzberg AF
    Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids.
    Am J Psychiatry. 2021;178:221-223.

    February 2021
  45. SUMMERS RF, Gorrindo T, Hwang S, Aggarwal R, et al
    Psychiatrist Burnout: Response to Schonfeld and Bianchi.
    Am J Psychiatry. 2021;178:204-205.

  46. SCHONFELD IS, Bianchi R
    Psychiatrist Burnout.
    Am J Psychiatry. 2021;178:204.

  47. FEDER A, Costi S, Rutter SB, Collins AB, et al
    A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
    Am J Psychiatry. 2021;178:193-202.
    PubMed     Abstract available

    January 2021
  48. SHMULEWITZ D, Aharonovich E, Witkiewitz K, Anton RF, et al
    The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.
    Am J Psychiatry. 2021 Jan 21:appiajp202020050610.
    PubMed     Abstract available

    November 2020
  49. SINHA R, Wemm S, Fogelman N, Milivojevic V, et al
    Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
    Am J Psychiatry. 2020 Nov 19:appiajp202020050609.
    PubMed     Abstract available

    October 2020
  50. COUGHLIN LN, Pfeiffer P, Ganoczy D, Lin LA, et al
    Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
    Am J Psychiatry. 2020 Oct 29:appiajp202020040454.
    PubMed     Abstract available

    Is Testosterone an Effective Hormonal Therapy for Women With Antidepressant-Resistant Major Depression?
    Am J Psychiatry. 2020;177:891-894.

  52. KALIN NH
    Insights Into Suicide and Depression.
    Am J Psychiatry. 2020;177:877-880.

    Using Genetics to Increase Specificity of Outcome Prediction in Psychiatric Disorders: Prospects for Progression.
    Am J Psychiatry. 2020;177:884-887.

  54. FIRTH J, Wootton RE, Carvalho AF
    Toward Preventive Psychiatry: The Role of Advanced Epidemiological Methods.
    Am J Psychiatry. 2020;177:888-890.

    The Elephant in the Room: What Burnout Is and What It Is Not.
    Am J Psychiatry. 2020;177:898-899.

  56. MEDINA-RODRIGUEZ EM, Madorma D, O'Connor G, Mason BL, et al
    Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice.
    Am J Psychiatry. 2020;177:974-990.
    PubMed     Abstract available

  57. DICHTEL LE, Carpenter LL, Nyer M, Mischoulon D, et al
    Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.
    Am J Psychiatry. 2020;177:965-973.
    PubMed     Abstract available

    August 2020
  58. CHOI KW, Stein MB, Nishimi KM, Ge T, et al
    An Exposure-Wide and Mendelian Randomization Approach to Identifying Modifiable Factors for the Prevention of Depression.
    Am J Psychiatry. 2020 Aug 14:appiajp202019111158.
    PubMed     Abstract available

    The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
    Am J Psychiatry. 2020;177:671-685.
    PubMed     Abstract available

    Chasing the Holy Grail: Developmentally Informed Research on Frontostriatal Reward Circuitry in Depression.
    Am J Psychiatry. 2020;177:660-662.

    Mental Health Treatment Utilization in Transgender Persons: What We Know and What We Don't Know.
    Am J Psychiatry. 2020;177:657-659.

  62. CARPENTER LL, Philip NS
    The Future Is Now? Rapid Advances by Brain Stimulation Innovation.
    Am J Psychiatry. 2020;177:654-656.

  63. THASE ME
    Charting Sea Changes in Outpatient Pharmacotherapy of Bipolar Disorder.
    Am J Psychiatry. 2020;177:651-653.

  64. DWYER JB, Aftab A, Radhakrishnan R, Widge A, et al
    Hormonal Treatments for Major Depressive Disorder: State of the Art.
    Am J Psychiatry. 2020;177:686-705.
    PubMed     Abstract available

    July 2020
  65. SUMMERS RF, Gorrindo T, Hwang S, Aggarwal R, et al
    Well-Being, Burnout, and Depression Among North American Psychiatrists: The State of Our Profession.
    Am J Psychiatry. 2020 Jul 14:appiajp202019090901.
    PubMed     Abstract available

  66. MUSLINER KL, Krebs MD, Albinana C, Vilhjalmsson B, et al
    Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
    Am J Psychiatry. 2020 Jul 14:appiajp202019111195.
    PubMed     Abstract available

  67. BOYER J
    COVID-19, Medication-Assisted Treatment, and Increased Risk for Further Respiratory Depression.
    Am J Psychiatry. 2020;177:636.

  68. LIN K, Yang BX, Luo D, Liu Q, et al
    The Mental Health Effects of COVID-19 on Health Care Providers in China.
    Am J Psychiatry. 2020;177:635-636.

    June 2020
  69. MALONEY SE, Rogers CE, Constantino JN
    Antidepressants, Pregnancy, and Autism: Setting the Record(s) Straight.
    Am J Psychiatry. 2020;177:479-481.

  70. VEGA ML, Newport GC, Bozhdaraj D, Saltz SB, et al
    Implementation of Advanced Methods for Reproductive Pharmacovigilance in Autism: A Meta-Analysis of the Effects of Prenatal Antidepressant Exposure.
    Am J Psychiatry. 2020;177:506-517.
    PubMed     Abstract available

  71. OSLER M, Jorgensen MB
    Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study.
    Am J Psychiatry. 2020;177:497-505.
    PubMed     Abstract available

    May 2020
  72. KALIN NH
    The Critical Relationship Between Anxiety and Depression.
    Am J Psychiatry. 2020;177:365-367.

  73. WASIL AR, Gillespie S, Shingleton R, Wilks CR, et al
    Examining the Reach of Smartphone Apps for Depression and Anxiety.
    Am J Psychiatry. 2020;177:464-465.

  74. SPELLMAN T, Liston C
    Toward Circuit Mechanisms of Pathophysiology in Depression.
    Am J Psychiatry. 2020;177:381-390.
    PubMed     Abstract available

  75. NESTOR SM, Blumberger DM
    Mapping Symptom Clusters to Circuits: Toward Personalizing TMS Targets to Improve Treatment Outcomes in Depression.
    Am J Psychiatry. 2020;177:373-375.

  76. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    The Rearing Environment and Risk for Major Depression: A Swedish National High-Risk Home-Reared and Adopted-Away Co-Sibling Control Study.
    Am J Psychiatry. 2020;177:447-453.
    PubMed     Abstract available

    Is Depression Nature or Nurture? Yes.
    Am J Psychiatry. 2020;177:376-377.

  78. PHILIP NS, Barredo J, Aiken E, Larson V, et al
    Informing Further Research in the Use of Brain Stimulation in Psychiatric Disorders: Response to Syed and Smith.
    Am J Psychiatry. 2020;177:466-467.

  79. SIDDIQI SH, Taylor SF, Cooke D, Pascual-Leone A, et al
    Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation.
    Am J Psychiatry. 2020;177:435-446.
    PubMed     Abstract available

  80. GRAY JP, Muller VI, Eickhoff SB, Fox PT, et al
    Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies.
    Am J Psychiatry. 2020;177:422-434.
    PubMed     Abstract available

    April 2020
  81. GU X, Guo T, Si Y, Wang J, et al
    Association Between Ambient Air Pollution and Daily Hospital Admissions for Depression in 75 Chinese Cities.
    Am J Psychiatry. 2020 Apr 21:appiajp202019070748.
    PubMed     Abstract available

  82. RAPPAPORT BI, Kandala S, Luby JL, Barch DM, et al
    Brain Reward System Dysfunction in Adolescence: Current, Cumulative, and Developmental Periods of Depression.
    Am J Psychiatry. 2020 Apr 7:appiajp201919030281.
    PubMed     Abstract available

  83. COLE EJ, Stimpson KH, Bentzley BS, Gulser M, et al
    Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression.
    Am J Psychiatry. 2020 Apr 7:appiajp201919070720.
    PubMed     Abstract available

    February 2020
  84. KALIN NH
    Treating Substance Use Disorders, Binge Eating, and Depression, and Identifying Factors Underlying Psychosis Risk.
    Am J Psychiatry. 2020;177:101-103.

  85. HUNTER AM, Leuchter AF
    Benzodiazepine Use and rTMS Outcome.
    Am J Psychiatry. 2020;177:172.

  86. KASTER TS, Downar J, Vila-Rodriguez F, Daskalakis ZJ, et al
    Caution When Continuing Benzodiazepines During rTMS: Response to Hunter and Leuchter.
    Am J Psychiatry. 2020;177:172-173.

  87. MATHEW SJ, Price RB
    Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring Change.
    Am J Psychiatry. 2020;177:107-109.

  88. CUSIN C, Sakurai H, Bentley K, Pedrelli P, et al
    All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment.
    Am J Psychiatry. 2020;177:173-174.

    December 2019
  89. SCHEELE D, Zimbal S, Feinstein JS, Delis A, et al
    Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage.
    Am J Psychiatry. 2019;176:982-986.

    November 2019
  90. MCSHANE R, Baldwin DS, McAllister-Williams RH, Stone JM, et al
    Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential.
    Am J Psychiatry. 2019;176:966.

    October 2019
  91. CROWELL AL, Riva-Posse P, Holtzheimer PE, Garlow SJ, et al
    Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression.
    Am J Psychiatry. 2019 Oct 4:appiajp201918121427.
    PubMed     Abstract available

    More Thoughts on Intranasal Esketamine: Response to Drevets et al.
    Am J Psychiatry. 2019;176:858-859.

  93. DREVETS WC, Singh JB, Hough D, Daly EJ, et al
    Comment on a Word to the Wise About Intranasal Esketamine.
    Am J Psychiatry. 2019;176:856-857.

    September 2019
  94. BECKER MA, Chandy A, Mayer JLW, Sachdeva J, et al
    Psychiatric Aspects of Infertility.
    Am J Psychiatry. 2019;176:765-766.

  95. ZOU R, Tiemeier H, van der Ende J, Verhulst FC, et al
    Exposure to Maternal Depressive Symptoms in Fetal Life or Childhood and Offspring Brain Development: A Population-Based Imaging Study.
    Am J Psychiatry. 2019;176:702-710.
    PubMed     Abstract available

    August 2019
  96. LOPES FL, McMahon FJ
    The Promise and Limits of Suicide Genetics.
    Am J Psychiatry. 2019;176:600-602.

  97. BORDER R, Johnson EC, Evans LM, Keller MC, et al
    Measurement Error Cannot Account for Failed Replications of Historic Candidate Gene-by-Environment Hypotheses: Response to Vrshek-Schallhorn et al.
    Am J Psychiatry. 2019;176:668-669.

  98. VRSHEK-SCHALLHORN S, Corneau GM, Starr LR
    Large Sample Sizes Cannot Compensate for Mismeasured Environments in Gene-by-Environment Research.
    Am J Psychiatry. 2019;176:667-668.

  99. RIGLIN L, Eyre O, Thapar AK, Stringaris A, et al
    Identifying Novel Types of Irritability Using a Developmental Genetic Approach.
    Am J Psychiatry. 2019;176:635-642.
    PubMed     Abstract available

    June 2019
  100. GORDON JA
    From Neurobiology to Novel Medications: A Principled Approach to Translation.
    Am J Psychiatry. 2019;176:425-427.

    A Word to the Wise About Intranasal Esketamine.
    Am J Psychiatry. 2019;176:422-424.

    May 2019
  102. PINE DS
    Heterogeneity in Major Depressive Disorder: Lessons From Developmental Research on Irritability.
    Am J Psychiatry. 2019;176:331-332.

  103. HEIFETS BD, Williams NR, Blasey C, Sudheimer K, et al
    Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin.
    Am J Psychiatry. 2019;176:412.

    April 2019
  104. RICHARDS M, Grzenda A, Nelson E, Gitlin M, et al
    Psychiatric Comorbidity in Moyamoya Disease and Preliminary Guidelines For Treatment.
    Am J Psychiatry. 2019;176:269-274.

    March 2019
    Caution Against Overinterpreting Opiate Receptor Stimulation as Mediating Antidepressant Effects of Ketamine.
    Am J Psychiatry. 2019;176:249.

  106. HEIFETS BD, Williams NR, Blasey C, Sudheimer K, et al
    Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to Sanacora.
    Am J Psychiatry. 2019;176:249-250.

    February 2019
  107. SANCHEZ-ROIGE S, Palmer AA, Fontanillas P, Elson SL, et al
    Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts.
    Am J Psychiatry. 2019;176:107-118.
    PubMed     Abstract available

    January 2019
  108. WIDGE AS, Rodriguez CI, Carpenter LL, Kalin NH, et al
    EEG Biomarkers for Treatment Response Prediction in Major Depressive Illness.
    Am J Psychiatry. 2019;176:82.

  109. WIDGE AS, Bilge MT, Montana R, Chang W, et al
    Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis.
    Am J Psychiatry. 2019;176:44-56.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.